National Bank Holdings Corporation
NYSE:NBHCBanks - Regional
+$0.34 today
- Market cap
- $1.61B
- Beta
- 0.78
- P/E (TTM)
- 15.2
- EPS (TTM)
- $2.78
- Dividend yield
- 2.95%
Volume 0.39M
Average 0.42M
NBHC Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
National Bank Holdings CorporationNYSE: NBHC
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How NBHC compares with its peers on the latest reported figures
- NBHC's LTM Mar 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for NBHC, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
STELStellar Bancorp, Inc. | LTM Mar 2026 | $0 | — | — | 0.0% |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding NBHC) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for NBHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 306.15M | 346.52M | 553.56M | 594.31M | 583.94M |
| Cost of Revenue | 4.53M | 54.58M | 141.76M | 199.64M | 179.97M |
| Gross Profit | 301.62M | 291.94M | 411.8M | 394.68M | 403.97M |
| Gross Margin | 98.5% | 84.2% | 74.4% | 66.4% | 69.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 131.86M | 130.91M | 148.71M | 155.62M | 154.55M |
| Operating Expenses | 186.65M | 205.75M | 236.2M | 249.43M | 261.24M |
| Depreciation & Amortization | 13.59M | 16.45M | 23.85M | 24.19M | 21.78M |
| EBITDA | 128.56M | 102.63M | 199.46M | 169.44M | 164.51M |
| EBITDA Margin | 42.0% | 29.6% | 36.0% | 28.5% | 28.2% |
| Operating Income | 114.97M | 86.18M | 175.6M | 145.25M | 142.73M |
| Operating Margin | 37.6% | 24.9% | 31.7% | 24.4% | 24.4% |
| Interest Income | 200.97M | 283.65M | 492.16M | 536.44M | 517.88M |
| Interest Expense | 13.82M | 17.85M | 133.46M | 192.88M | 171.27M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | (9.1M) |
| Income Before Tax | 114.97M | 86.18M | 175.6M | 145.25M | 133.63M |
| Pre-Tax Margin | 37.6% | 24.9% | 31.7% | 24.4% | 22.9% |
| Income Tax Expense | 21.37M | 14.91M | 33.55M | 26.43M | 24.06M |
| Net Income | 93.61M | 71.27M | 142.05M | 118.82M | 109.57M |
| Net Margin | 30.6% | 20.6% | 25.7% | 20.0% | 18.8% |
| EPS (Basic) | 3.04 | 2.20 | 3.74 | 3.10 | 2.86 |
| EPS (Diluted) | 3.01 | 2.18 | 3.72 | 3.08 | 2.85 |
| Weighted Avg Shares | 30.73M | 32.36M | 37.94M | 38.21M | 38.18M |
| Weighted Avg Shares (Diluted) | 31.07M | 32.68M | 38.11M | 38.42M | 38.18M |
National Bank Holdings Corporation
NYSE:NBHC
Intrinsic Alpha fair value
Locked
Current Price
$36.48
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.